Papers

Peer-reviewed
2015

GIPR gene polymorphism and weight gain in patients with schizophrenia treated with olanzapine

Journal of Neuropsychiatry and Clinical Neurosciences
  • Shin Ono
    • ,
  • Yutaro Suzuki
    • ,
  • Naoki Fukui
    • ,
  • Kazushi Sawamura
    • ,
  • Takuro Sugai
    • ,
  • Junzo Watanabe
    • ,
  • Nobuto Tsuneyama
    • ,
  • Toshiyuki Someya
Volume
27
Number
2
First page
162
Last page
164
Language
English
Publishing type
Research paper (scientific journal)
DOI
10.1176/appi.neuropsych.13120389
Publisher
American Psychiatric Association
Association between gastric inhibitory polypeptide receptor polymorphism, rs10423928, and body mass index in olanzapinetreated schizophrenia was examined. Body mass index change for the A/T+A/A genotypes was significantly higher than that for the T/T genotype. rs10423928 may predict weight gain in schizophrenia.
Link information
DOI
https://doi.org/10.1176/appi.neuropsych.13120389
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/25321336
ID information
  • DOI : 10.1176/appi.neuropsych.13120389
  • ISSN : 1545-7222
  • ISSN : 0895-0172
  • Pubmed ID : 25321336
  • SCOPUS ID : 84929673787
Export
BibTeX RIS
To Papers list